TriSalus Life Sciences GAAP EPS of -$0.39 misses by $0.17, revenue of $9.2M beats by $0.16M

1 month ago 5
  • TriSalus Life Sciences press release (NASDAQ:TLSI): Q1 GAAP EPS of -$0.39 misses by $0.17.
  • Revenue of $9.2M (+41.5% Y/Y) beats by $0.16M.
  • Updated 2025 Guidance

    TriSalus is confirming its revenue guidance of at least 50% growth due to continued commercial momentum

Recommended For You

More Trending News

Read Entire Article